Nordic Bioscience A/S | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Global Research Initiative for Patients Screening on MASH	Body Weight, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, hyperinsulinism, hypertensive disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder	Recruiting	Not stated	2024-08-01		NCT05651724
Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.	Chronic Liver Disease	Not yet recruiting	Not stated	2024-01-03		NCT05312853
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF	Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease, idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Active, not recruiting	Not stated	2023-12-22		NCT02755441
Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers	Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver disease, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder	Recruiting	Not applicable	2022-09-01		NCT03308916